Pancreatic Cancer Scotland Collaborations Seek to Open up Clinical Research as Care Options 2020 and Beyond

Pancreatic Cancer Scotland Collaborations Seek to Open up Clinical Research as Care Options 2020 and Beyond

Formed in 2010 by a group of patients, caregivers, nurses, and doctors in Scotland, Pancreatic Cancer Scotland (PCS) has a bold vision that in the coming decade, pancreatic cancer survival rates will dramatically change for the better. Although little has changed in 50 years, they are committed to change now given 2020 is right around the corner.

Action Needed Now

Although death rates have declined for many other cancers, they haven’t for pancreatic cancer—headed in the other, wrong direction. Seven hundred eighty-one patients in Scotland died from pancreatic cancer in 2017, and 811 in 2018 reports the Daily Record. Unfortunately, ISD (Information Services Division) Scotland predicts a 49.9% increase by 2027.

Collaborative and Committed

PCS, a collaborative-focused group, recently inked a partnership with NHS Greater Glasgow and Clyde (NHSGGC) funding a dedicated pancreatic cancer clinical nurse specialist, Kimberley Booth, reports the Daily Record. Ms. Booth is based at Glasgow Royal Infirmary for the offering of pancreatic cancer care navigation services. The role focuses on three critical areas, including 1) the West of Scotland pancreatic team, 2) the groundbreaking “Precision-Panc” research project, and 3) PCS.

Gateway to Clinical Research as a Care Option in Scotland

Although some patients in Scotland may benefit from participating in clinical trials, few are aware of this option. PCS’ Ms. Booth will serve as a kind of navigator helping to assist patients and their families in understanding what clinical trials are and whether there may be a fit. Ms. Booth is highly qualified for this role, having served for five years at Beatson West of Scotland Cancer Centre. She was involved extensively with the administration of cancer treatment and understood the patient care journey.

Connection to Research: Precision-Panc Platform 

This platform, a UK-wide personalized medicine project, was founded in 2017 to accelerate scientific discovery to help improve pancreatic survival rates. Based in Glasgow, Precision-Panc centers on collaboration between clinicians, scientists, and other experts and committed groups, such as PCS, to accelerate cures. Cancer Research UK mostly funds the multi-million-pound research program.

Call to ActionAre you based in Scotland? Have you or a loved one been diagnosed with pancreatic cancer? Consider reaching out to PCS—see their link